Related Experiment Video
Updated: Jun 5, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Audit of state-funded antiviral treatment for chronic hepatitis C in Qatar
1Department of Gastroenterology, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar. aniljohn44@gmail.com
Abstract:
Hepatitis C virus (HCV) infection is a major public health problem in the Middle East. A database of 400 patients with chronic HCV in Qatar was retrospectively analysed: 242 patients underwent antiviral treatment, of whom 212 (87.6%) were naïve to treatment. The response to treatment and the predictors of response were studied. The largest group of patients were of Egyptian origin. The rate of sustained virological response (SVR) varied significantly between patients with HCV genotypes 2 or 3 (79.6%) and genotype 1 (45.6%) and 4 (the predominant genotype) (51.0%). Multivariate analysis showed that the independent predictors of SVR were age < 45 years, infection with genotypes 2 or 3, low fibrosis score on liver biopsy and naïve treatment status.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:
Antiviral Nucleoside Inhibitors
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

